25, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical, was recently ...

As Hanmi Pharmaceutical sued Lim Jong-hoon, CEO of Hanmi Science, the holding company, the battle between the two sides is intensifying. Hanmi Pharmaceutical said it has filed a complaint with the ...

SAN FRANCISCO ― Hanmi Pharmaceutical is poised to bring a new chapter to obesity treatment, a topic that has garnered significant attention at this year’s JP Morgan Healthcare Conference.

Choi In-young, head of the Hanmi Pharmaceutical R&D Center, noted during a briefing at the JP Morgan Healthcare Conference (JPM) held in San Francisco on the 15th (local time) that "the biggest ...

Hanmi Pharmaceutical CEO Park Jae-hyun at the extraordinary shareholder meeting held in Songpa District, southern Seoul, on Thursday. [YONHAP] Efforts to seize the management rights of Hanmi ...

Seven key executives of Hanmi Pharmaceutical have expressed their support for a professional management system led by CEO Park Jae-hyun. They are in favor of forming a 'professional management ...

Market Open. The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi Pharmaceutical, was recently presented at ...